Here are 11 key notes on orthopedic and spine device companies from the past week.
Dublin, Ireland-based Medtronic is planning to sell a portion or all of its medical supplies business, unnamed sources revealed to Bloomberg.
Knoxville, Tenn.-based ChoiceSpine acquired Gainesville, Fla.-based Exactech's spine products business.
Zimmer Biomet reported 2016 fourth quarter net sales of about $2.01 billion, which translates to a 4.1 percent increase from 2015.
Carlsbad, Calif.-based SeaSpine is commercially launching its Vu a•POD Prime NanoMetalene System.
Virginia Spine Institute surgeons performed the Mid-Atlantic region's 1st Mazor Robotics' Mazor X surgery.
WishBone Medical, a pediatric orthopedic devices company, is opening in Warsaw, Ind., and it hired former Congressman Marlin Stutzman as president.
Gateway Investment Advisers, owner of $2.56 million-worth Stryker shares, cut back its stake in company shares.
Mainstay Medical's ReActiv8, which treats back pain, treats chronic back pain, recently received the CE mark of approval.
Lexington, Ky.-based Intralink-Spine is optimistic after its Rejuve treatment showed positive results in a six-month study.
SpinalCyte, a tissue engineering technology company based in Houston, announced the enrollment of the first patient to partake in a study for the development of CybroCell.
Ortho Sales Partners, a Scottsdale, Ariz.-based consulting firm that assists orthopedic and spine implant manufacturers to commercialize their products, hired Tony Passalacqua as their vice president of sales operations and supply chain.